You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 25 Next »

I. Suggested Operational Fix

No.ProponentTopicDeferred to Phase 2?FileTentative Presentation Date
1Kristine Dorrain

B. NOTICE

3. Other topics




2Maxim Alzoba

F. REMEDIES

2. Duration of Suspension Period

3. Review of Implementation




3Zak Muscovitch

F. REMEDIES

2. Duration of Suspension Period

3. Review of Implementation




4George Kirikos

F. REMEDIES

4. Other topics




II. Draft Policy Recommendation 

No.ProponentTopic (Mapped to the Super Consolidated URS Topics Table)Deferred to Phase 2?FileNotes
5George Kirikos

A. THE COMPLAINT

3. Limited filing period

Yes

6Claudio DiGangi

A. THE COMPLAINT

8. Other topics




7George Kirikos

B. NOTICE

1. Receipt by registrant (Notice - feedback from Complainant & Respondent)

Yes

8George Kirikos

C. RESPONSE

1. Duration of response period

Yes

9David McAuley

C. RESPONSE (primary topic)

1. Duration of response period

==

G. APPEAL (secondary topic)

2. De novo review




10Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

C. RESPONSE (primary topic)

1. Duration of response period

==

G. APPEAL (secondary topic)

2. De novo review




11Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

C. RESPONSE

3. Response fee




12George Kirikos

D. STANDARD OF PROOF

1. General

Yes

13Marie Pattullo (AIM - European Brands Association)

F. REMEDIES

1. Scope of remedies




14Marie Pattullo (AIM - European Brands Association)

F. REMEDIES

1. Scope of remedies




15Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

F. REMEDIES

1. Scope of remedies




16Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

F. REMEDIES

1. Scope of remedies

2. Duration of suspension period




17Marie Pattullo (AIM - European Brands Association)

F. REMEDIES

2. Duration of suspension period




18George Kirikos

G. APPEAL

1. Appeals process

Yes



19George Kirikos

G. APPEAL

1. Appeals process

Yes



20George Kirikos

G. APPEAL

1. Appeals process

Yes



21Marie Pattullo (AIM - European Brands Association)

I. COST

1. Cost allocation model




22Brian Winterfeldt; Christopher Thomas; Colin O’Brien; Griffin Barnett; Jeff Neuman; John McElwaine; Lori Schulman; Pascal Boehner; Paul McGrady; Susan Payne

I. COST

1. Cost allocation model




23George Kirikos

I. COST

1. Cost allocation model

Yes



24George Kirikos

J. LANGUAGE ISSUES

1. Language issues, including current requirements for complaint, notice of complaint, response, determination




25Zak Muscovitch

J. LANGUAGE ISSUES

1. Language issues, including current requirements for complaint, notice of complaint, response, determination




26Zak Muscovitch

M. URS PROVIERS

1. Evaluation of URS providers and their respective processes (including training of panelists)




27Zak Muscovitch

M. URS PROVIERS

1. Evaluation of URS providers and their respective processes (including training of panelists)




28Zak Muscovitch

M. URS PROVIERS

2. Conflict of interest




29George Kirikos

M. URS PROVIDERS

(no applicable subheading at present)




30George Kirikos

N. ALTERNATIVE PROCESSES

1. Possible alternative(s) to the URS, e.g. summary procedure in the UDRP

Yes



31David McAuley

(no applicable subheading at present)




III. Other 

No.ProponentTopicDeferred to Phase 2?
File
32George Kirikos

N. ALTERNATIVE PROCESSES

1. Possible alternative(s) to the URS, e.g., summary procedure in the UDRP




33George Kirikos(no applicable subheading at present)Yes




  • No labels